165 related articles for article (PubMed ID: 29648642)
1. A novel forehead temperature-regulating device for insomnia: a randomized clinical trial.
Roth T; Mayleben D; Feldman N; Lankford A; Grant T; Nofzinger E
Sleep; 2018 May; 41(5):. PubMed ID: 29648642
[TBL] [Abstract][Full Text] [Related]
2. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.
Morin CM; Vallières A; Guay B; Ivers H; Savard J; Mérette C; Bastien C; Baillargeon L
JAMA; 2009 May; 301(19):2005-15. PubMed ID: 19454639
[TBL] [Abstract][Full Text] [Related]
3. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
Jacobs GD; Pace-Schott EF; Stickgold R; Otto MW
Arch Intern Med; 2004 Sep; 164(17):1888-96. PubMed ID: 15451764
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.
Sivertsen B; Omvik S; Pallesen S; Bjorvatn B; Havik OE; Kvale G; Nielsen GH; Nordhus IH
JAMA; 2006 Jun; 295(24):2851-8. PubMed ID: 16804151
[TBL] [Abstract][Full Text] [Related]
6. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
Ivgy-May N; Ruwe F; Krystal A; Roth T
Sleep Med; 2015 Jul; 16(7):838-44. PubMed ID: 26047892
[TBL] [Abstract][Full Text] [Related]
7. Effect of Transcranial Alternating Current Stimulation for the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial.
Wang HX; Wang L; Zhang WR; Xue Q; Peng M; Sun ZC; Li LP; Wang K; Yang XT; Jia Y; Zhou QL; Xu ZX; Li N; Dong K; Zhang Q; Song HQ; Zhan SQ; Min BQ; Fan CQ; Zhou AH; Guo XH; Li HB; Liang LR; Yin L; Si TM; Huang J; Yan TY; Cosci F; Kamiya A; Lu J; Wang YP
Psychother Psychosom; 2020; 89(1):38-47. PubMed ID: 31846980
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
[TBL] [Abstract][Full Text] [Related]
9. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
[TBL] [Abstract][Full Text] [Related]
10. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.
Roth T; Rogowski R; Hull S; Schwartz H; Koshorek G; Corser B; Seiden D; Lankford A
Sleep; 2007 Nov; 30(11):1555-61. PubMed ID: 18041488
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
13. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
14. REM and NREM power spectral analysis on two consecutive nights in psychophysiological and paradoxical insomnia sufferers.
St-Jean G; Turcotte I; Pérusse AD; Bastien CH
Int J Psychophysiol; 2013 Aug; 89(2):181-94. PubMed ID: 23770085
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
16. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
[TBL] [Abstract][Full Text] [Related]
17. Effects of a forehead cooling device in veterans with chronic insomnia disorder and co-morbid medical and psychiatric conditions: a pilot study.
Mysliwiec V; Neylan TC; Chiappetta L; Nofzinger EA
Sleep Breath; 2021 Mar; 25(1):441-448. PubMed ID: 32572683
[TBL] [Abstract][Full Text] [Related]
18. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
19. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
